Duloxetine: a new selective and dual-acting antidepressant.

about

Duloxetine in the treatment of major psychiatric and neuropathic disorders.Impurities in Drug Products and Active Pharmaceutical Ingredients.Development and validation of a stability-indicating RP-HPLC method for duloxetine hydrochloride in its bulk and tablet dosage form.

P2860

Q34770302-9A34FD9C-4891-48EC-A4B4-535CD1E20C73 Q38968088-0CE4D842-85E5-41CB-AB8F-834F0C0AADC9 Q41375549-D05A8F76-2325-4D4D-9864-9A27B0A13E10

P2860

Duloxetine: a new selective and dual-acting antidepressant.

Item

http://www.wikidata.org/entity/Q36407366

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Duloxetine: a new selective and dual-acting antidepressant.

@ast

Duloxetine: a new selective and dual-acting antidepressant.

@en

type

Item

label

Duloxetine: a new selective and dual-acting antidepressant.

@ast

Duloxetine: a new selective and dual-acting antidepressant.

@en

prefLabel

Duloxetine: a new selective and dual-acting antidepressant.

@ast

Duloxetine: a new selective and dual-acting antidepressant.

@en

P1476

Duloxetine: a new selective and dual-acting antidepressant.

@en

P2093

Edith Schneider

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Möller

http://www.w3.org/2001/XMLSchema#string

Michael Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

Duloxetine vs. placebo in patients with painful diabetic neuropathy.

The outcome of physical symptoms with treatment of depression.

Effect of age on the pharmacokinetics of duloxetine in women.

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.

P304

421-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.4.421

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16503814

http://www.w3.org/2001/XMLSchema#string

Duloxetine: a new selective and dual-acting antidepressant.

about

P2860

P2860

Duloxetine: a new selective and dual-acting antidepressant.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698